Steve Gershick

Steve Gershick has substantial, hands-on experience in operations, business planning and corporate finance, debt and equity-based seed, venture, institutional, and PIPE financing. Interfacing between the various levels of the investment community in the U.S. with both private and public companies, Mr. Gershick is well versed in strategic alliance formation and management, mergers & acquisitions, and global technology licensing.

After graduating in Business Administration from California State University in 1977, Mr. Gershick obtained his Certified Public Accountant and Chartered Global Management Accountant accreditations. He joined PrimeGen as COO/CFO from 2004-2008, and had been a member of the Board of Managers and Chief Financial Officer since 2014.

Mr. Gershick has also served as CFO and COO for several private and public companies in technology, biotechnology and life sciences, including NuRX Pharmaceuticals, a clinical stage biopharmaceutical company, and led the health services diligence and finance teams for a boutique merchant banking firm, including a USD$100 million Special Purpose Acquisition Company funded by Citigroup.